Marinus Pharmaceuticals (MRNS)

No shares available to borrow for Marinus Pharmaceuticals (MRNS)

N/A

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Marinus Pharmaceuticals (MRNS) - cost to borrow from 2025 to 2023

Marinus Pharmaceuticals (MRNS) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company	Cost to borrow (% year)	Shares available	Country
AcelRx Pharmaceuticals ACRX	9.2451%	0.95 M	🇺🇸 USA
Eagle Pharmaceuticals EGRX	0.8702%	0.35 M	🇺🇸 USA
Endo International ENDPQ	6.8513%	0 M	🇮🇪 Ireland
Supernus Pharmaceuticals SUPN	0.2769%	1 M	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Marinus Pharmaceuticals (MRNS) - Cost to borrow shares

No shares available to borrow for Marinus Pharmaceuticals (MRNS)